Latest News about MRK
Recent news which mentions MRK
The 7 Best Healthcare Stocks to Buy for 2021
January 20, 2021
From InvestorPlace
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
January 20, 2021
From Benzinga
Why Gilead Sciences Stock Is Jumping Today
January 19, 2021
From Motley Fool
The Week Ahead In Biotech: FDA To Issue Decisions On Merck And Aurinia Drug Applications
January 16, 2021
From Benzinga
Novavax Hires Regulatory Expert As Coronavirus Vaccine Inches Closer To Emergency Use Filing
January 15, 2021
From Benzinga
10 Health Care Stocks With Unusual Options Alerts In Today's Session
January 15, 2021
From Benzinga
Moderna's Coronavirus Vaccine Secures Swiss Regulatory Approval
January 12, 2021
From Benzinga
The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue
January 12, 2021
From Benzinga
3 Coronavirus Stocks to Stay Miles Away From in 2021
January 12, 2021
From Motley Fool
The Top 3 Biotech Stocks to Buy in 2021
January 10, 2021
From Motley Fool
From Motley Fool
Moderna Has Big Plans For 2021
January 07, 2021
From Benzinga
From Motley Fool
The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration
January 07, 2021
From Benzinga
From Motley Fool
Biden’s defense and economic teams aren’t ready to battle China
January 06, 2021
From MarketWatch
3 Big Potential Catalysts for Moderna in 2021
January 06, 2021
From Motley Fool
Got $1,000? These 2 Top Stocks Can Make You Rich
January 05, 2021
From Motley Fool
Meet the 2021 Dogs of the Dow
January 05, 2021
From Motley Fool
From Benzinga
These Were the 5 Top Genetics Stocks of 2020
December 31, 2020
From Motley Fool
From Benzinga
These are the best-performing Nasdaq and S&P 500 stocks of 2020
December 29, 2020
From MarketWatch
From Motley Fool
Merck and AstraZeneca's Cancer Drug Wins 3 New Approvals in Japan
December 28, 2020
From Motley Fool
From Motley Fool
Meet Moderna's Most Likely Blockbusters After Its COVID Vaccine
December 24, 2020
From Motley Fool
COVID News Flow: Pfizer-BioNTech's US Vaccine Supply Deal, Merck Strikes $356M Contract, Sorrento Files For EUA Of Rapid Test
December 23, 2020
From Benzinga
Better Buy: Veeva Systems vs. Zendesk
December 23, 2020
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.